Trial Profile
ALIMTA [pemetrexed] plus carboplatin as front-line chemotherapy for patients with locally advanced or metastatic non-small cell lung cancer: a phase 2 clinical trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2005
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 21 Sep 2005 New trial record.